Showing results (211-220 of 514) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|February 13, 2023
Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative ColitisJaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Crohn'S & Colitis 360|December 5, 2025
Real-World Effectiveness of Risankizumab in Crohn's Disease: Outcome Data for an IL-23 Inhibitor from the Middle EastMohamed Nasir Alzaabi, Thaer Khaleel Swaid, Hosameldin Abdelrahman Ahmed, et al.
Crohn'S & Colitis 360|August 11, 2020
Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD PatientsMatthias Breidert, Pierre Eftekhari, François Louis, et al.
Crohn'S & Colitis 360|May 14, 2023
Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and EnablersRia Kanazaki, Ben Smith, Afaf Girgis, et al.
Crohn'S & Colitis 360|August 13, 2025
Anemia in Inflammatory Bowel Disease: Practice Patterns and Clinical Outcomes in a Large National Veterans CohortJared A Sninsky, Carolyn Brooks, Shubhada Sansgiry, et al.
Crohn'S & Colitis 360|August 5, 2025
Clinical Characteristics of Patients With Ulcerative Colitis and Small Intestinal MalignancyCaroline G Olson, Michael Picco, Francis A Farraye, et al.
Crohn'S & Colitis 360|July 16, 2025
Cannabis use in Patients With Inflammatory Bowel Disease is Associated With Longer Endoscopic Duration and Endoscopic InflammationLauren Loeb, Alexander Hochwald, Michael F Picco, et al.
Pageof 52